Review Article Cytochromes P450 in fungi
@article{Bossche1998ReviewAC, title={Review Article Cytochromes P450 in fungi}, author={Hugo F. Vanden Bossche and Lucien M. H. Koymans}, journal={Mycoses}, year={1998}, volume={41} }
Summary. The article gives an overview on the history of the discovery of P450 cytochromes and on their occurrence in nature, especially on their interactions with metabolic pathways in fungi. The significance of the P450 cytochromes in the ergosterol synthesis as well as in the inhibitory mechanisms caused by imidazole and triazole antimycotics is described is detail.
67 Citations
Fifty Years of Cytochrome P450 Research: Examples of What We Know and Do Not Know
- Biology
- 2014
Some of the early experimental groundwork including P450 multiplicity and activity, electron transfer, and cellular localization that led to the early understanding of the molecular properties of P450 enzymes are described.
Synthesis and in vitro / in vivo assessment of conjugates with antifungal activity
- Biology
- 2017
Comparative evaluation of the antifungal activity of voriconazole and a new propiconazoles derivative (MXP405) against fluconazole-resistant yeast isolates.
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
- Biology, ChemistryJournal of veterinary pharmacology and therapeutics
- 2003
A limited number of antifungal agents is licensed for use in animals, however, many of those available for the treatment of mycoses in humans are used by veterinary practitioners. This review…
Fungal cytochrome P450 sterol 14α-demethylase (CYP51) and azole resistance in plant and human pathogens
- BiologyApplied Microbiology and Biotechnology
- 2012
Although no crystal structure is available yet for any fungal CYP51, homology modeling using structures from other origins as template allowed deducing models for fungal orthologs and served to map amino acid changes known from clinical and field isolates to explain CYP 51-based azole resistance.
Calmodulin inhibition as a mode of action of antifungal imidazole pharmaceuticals in non-target organisms
- BiologyToxicology research
- 2020
It is suggested that CaM inhibition by miconazole leads to protein overexpression that compensates for the loss in the protein activity, with no measurable downstream effects on NO pathways.
2-Aminobenzothiazole derivatives: search for new antifungal agents.
- Chemistry, BiologyEuropean journal of medicinal chemistry
- 2013
Efficacy of some natural compounds as antifungal agents
- ChemistryPharmacognosy reviews
- 2012
This account describes structure and activities of selected agents isolated from various natural sources, including a number of potent antifungals originated fromVarious natural sources.
Synthesis, Antifungal Activity, and Docking Study of Some New 1,2,4‐triazole Analogs
- ChemistryChemical biology & drug design
- 2011
Docking study of the newly synthesized compounds showed that all new compounds have similar binding mode in the active site of fungal enzyme P450 cytochrome lanosterol 14α‐demethylase.
Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.
- BiologyMicrobiology
- 1999
The cytochrome P450 14alpha-demethylase, encoded by the ERG11 (CYP51) gene, is the primary target for the azole class of antifungals and mutations found in the two N-terminal regions only Y132H was demonstrated to be of importance for azole resistance.
Design, Synthesis and Evaluation of New Azoles as Antifungal Agents: a Molecular Hybridization Approach
- Biology, ChemistryPharmaceutical Chemistry Journal
- 2016
Compound 9 containing 2-methyl-5-nitroimidazole moiety proved to be the most potent compound and was more active than the reference drugs fluconazole and ketoconazole against S. cerevisiae.
References
SHOWING 1-10 OF 70 REFERENCES
Biochemical Targets for Antifungal Azole Derivatives: Hypothesis on the Mode of Action
- Biology, Chemistry
- 1985
An amazing number of antifungal agents are found within the group of azole-containing compounds, and they show excellent activity against phytopathogenic fungi.
Heterogeneity within the alkane‐inducible cytochrome P450 gene family of the yeast Candida tropicalis
- Biology, ChemistryFEBS letters
- 1989
P450 inhibitors of use in medical treatment: focus on mechanisms of action.
- Medicine, BiologyPharmacology & therapeutics
- 1995
Inhibition of ergosterol synthesis in Ustilago maydis by the fungicide triarimol.
- Chemistry, BiologyBiochemical and biophysical research communications
- 1972
Involvement of cytochrome P-450 in Δ22-desaturation in ergosterol biosynthesis of yeast
- Chemistry, Biology
- 1981
Anti-Candida drugs--the biochemical basis for their activity.
- Biology, ChemistryCritical reviews in microbiology
- 1987
Different biochemical targets for the antifungals of use in candidosis are discussed in this paper, which include the allylamines and the fluorinated pyrimidine, flucytosine.
Mode of Action of Antifungals of Use in Immunocompromised Patients. Focus on Candida Glabrata and Histoplasma Capsulatum
- Biology, Medicine
- 1990
The most important antifungals for use in immunocompromised patients interfere with targets in the plasma membrane, nucleus or smooth endoplasmic reticulum (allylamines, morpholines, azole derivatives).
Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans
- Biology, ChemistryAntimicrobial Agents and Chemotherapy
- 1993
The complete inhibition of ergosterol synthesis and the accumulation of the 4,4,14-trimethylsterol and of the 3-ketosteroid together with the absence of sterols, such as 14 alpha-methylfecosterol and lanosterol, are at the origin of the high activity of itraconazole against C. neoformans.
Crystallization and preliminary x-ray diffraction analysis of P450terp and the hemoprotein domain of P450BM-3, enzymes belonging to two distinct classes of the cytochrome P450 superfamily.
- Chemistry, BiologyProceedings of the National Academy of Sciences of the United States of America
- 1992
Characterization of the crystal forms of two soluble, bacterial enzymes: cytochrome P450terp [class I enzyme from a Pseudomonas species (product of CYP108 gene)] and the hemoprotein domain of cytochromes P450BM-3 [class II enzyme from Bacillus megaterium (Product of the CYP102 gene)].